Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,939.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Hikma hits Tullow Oil out of UK's FTSE 100

Wed, 04th Mar 2015 18:38

* Tullow relegated to FTSE 250

* Weir Group remains in the FTSE 100

* AA, Imagination Tech, Virgin Money join FTSE 250

* Afren, Game Digital, Oxford Instruments out of FTSE 250 (Adds detail on reshuffle, background)

By Sudip Kar-Gupta

LONDON, March 4 (Reuters) - Hikma Pharmaceuticals has pushed Tullow Oil out of Britain's benchmark FTSE100 equity index, FTSE Group announced on Wednesday,following a drop in Tullow's stock price and a rise in Hikma'sshares.

Getting into the FTSE 100 can often fuel further demand fora company's shares, since funds that track the FTSE or invest inthe index can then add that stock to their portfolio.

The rankings are decided on market capitalisation. Companieswith the lowest market cap in the FTSE 100 drop into the FTSE250 mid-cap index, and companies with the highest marketcap on the FTSE 250 get promoted into the top index.

Tullow has been hit by a slump in the oil price and concernsthat a boundary dispute between Ivory Coast and Ghana coulddelay a project off the West African coast.

By contrast, in November Hikma raised its annual revenuegrowth target due to strong demand for itsproducts.

Engineering company Weir Group, which had been seenas at risk of being demoted from the FTSE 100, also managed tostay in the top UK equity index.

VIRGIN MONEY TO JOIN FTSE 250

Shares in Tullow Oil closed down 1.3 percent on Wednesday,while Hikma's shares rose 2.5 percent. Tullow Oil shares havefallen around 13 percent since the start of 2015, while Hikmahas risen around 24 percent.

Among other changes, motoring group and car insurer AA Plc -- which floated on the stock market last year -- wonpromotion to the FTSE 250 index.

Imagination Technologies, which supplies graphicsprocessing to Apple Inc ajd British bank Virgin Money are also set to enter the mid-cap index.

Oil producer Afren, which has defaulted on its 2016bonds, will drop out of the FTSE 250 index along with videogames retailer Game Digital and nanotechnology toolsmanufacturer Oxford Instruments.

The changes to the FTSE 100 and 250 indexes will take effectat the start of trading on March 23. (Editing by Atul Prakash; Editing by Andrew Heavens)

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.